Condition
Meningococcal Infections clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Meningococcal Infections clinical trials that are recruiting, at sites in 2 countries (most in Denmark (1), South Korea (1)). By phase: Phase 4 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Meningococcal conjugate vaccine for healthy adults aged 19–55
This will test a single dose of the EG-MCV4 meningococcal conjugate vaccine to see if it produces protective antibodies and is safe in healthy adults aged 19 to 55.
-
Vaccination safety and immune response in adults with HIV
This study is testing how safe and effective meningococcal and pneumococcal vaccines are for adults with HIV who are on treatment.
Related topics
Quick answers
How many Meningococcal Infections clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Denmark (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.